
339: RFK Jr.'s confirmation hearings, MASH drugs, and a controversial obesity ad
The Readout Loud
Shifting Paradigms in Biotech Venture Capital
This chapter explores Curibio's innovative fundraising strategies as a biotech accelerator, emphasizing their commitment to early-stage financing outside the norm of traditional venture capital. The discussion contrasts their modest fund size with larger industry trends, highlighting a potential shift in supporting innovative startups.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.